Dr. George Li is the Deputy General Manager at Exploring Health. He earned his master's degree from Nankai University, and his Ph.D. from Sun Yat-sen University in molecular medicine. Dr. Li has eight years of entrepreneurial/industrial experience. He previously worked for CytoTest Biotech, USA, and set up their Beijing Branch. As a branch leader, he was in charge of sales the in Asia and the Middle East. Dr. Li was also trained at the NIH / NCI Thomas Ried Laboratory in the United States. He is familiar with many molecular biomedical techniques, and is well-versed in the company's commercial operations, marketing, and sales.

       Recently Dr Li helped to set up an in vitro anti-metastasis screening system. Through this system/platform, he and his team have identified more than 40 leader anti-metastasis compounds from 15,000 molecules (drugs）in three compound libraries. Based on the validation data, the screening system is high-throughput, highly-efficient, reliable, and stable. The in vivo animal screening system is also maturing, as we look for fruitful cooperation.